Why LQDA fell 20.3% on Oct 1 2026: patent infringement ruling

THE DAY ON THE LIST · 1 EVENT

1. 08:15 ET
   MOVER · PRE-MARKET

   $24.11 · ▼ 20.3% ON THE DAY · 83.7× 5M RVOL · RANK #9

   ✓JUSTIFIEDCONFIDENCE5/5

   LQDA is down 6.4% pre-market after a federal court found two United Therapeutics patent claims valid and infringed, following a 57.2% decline in the prior session. The additional analyst downgrade reinforces negative sentiment, but the move is modest relative to the litigation ruling's potential impact on YUTREPIA.

   WHYA 6.4% pre-market decline is proportionate to a court ruling validating infringement of two key patent claims after the stock already fell 57.2%.

   ANALYZED 07:59 ET · 15 MIN AGO · OPENAI/GPT-5.6-LUNA

   THE ROW AND SESSION LEVELS AT 08:15 ET

   LAST24.11

   DAY▼ 20.3%

   5 MIN▼ 9.33%

   5M RVOL83.7×

   5M $VOL$2.6M

   FLOAT*89.5M

   RANK#9

   SESSIONPRE-MARKET

   VWAP27.82

   HOD30.27

   LOD25.10

   OR HIGH—

   OR LOW—

   PREV CLOSE30.26

   PM HIGH30.27

   PM LOW25.10

   GAP▼ 16.92% (indicated)

   * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE

   — MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO